Metformin therapy, a type 2 diabetes treatment, has been shown to depend on GDF15 to lower body weight in mice and plasma GDF15 levels increased up to 40% upon metformin therapy in humans (Coll et al., 2020; Day et al., 2019). The gene discussed is GDF15; the disease is type 2 diabetes mellitus.